Page 2 - Heart Failure Clinical Guidelines

2

Contents

I. GENERAL HEART FAILURE PATIENT ............................................................................................................ 4
A. Initial Evaluation for Heart Failure Patient ........................................................................................... 4

B. Long-Term Medical Management ........................................................................................................ 4
C. Long-Term Follow-up Schedule ............................................................................................................ 5

D. Nutrition ............................................................................................................................................... 6
E. Exercise ................................................................................................................................................. 6
F. Advanced Therapies .............................................................................................................................. 8

II. DILATED CARDIOMYOPATHY .................................................................................................................... 9
A. Initial Evaluation for Patient with Dilated Cardiomyopathy ................................................................. 9

B. Long-Term Medical Management for Dilated Cardiomyopathy........................................................... 9
C. Long-Term Follow-up Schedule for Dilated Cardiomyopathy .............................................................. 9

III. RESTRICTIVE CARDIOMYOPATHY ........................................................................................................... 10
A. Initial Evaluation for Patient with Restrictive Cardiomyopathy ......................................................... 10

B. Medical Management for Restrictive Cardiomyopathy ..................................................................... 10
C. Long-Term Follow-up Schedule for Restrictive Cardiomyopathy ....................................................... 10
IV. HYPERTROPHIC CARDIOMYOPATHY ...................................................................................................... 12

A. Initial Evaluation for a Patient with Hypertrophic Cardiomyopathy .................................................. 12
B. Long-Term Medical Management for Hypertrophic Cardiomyopathy ............................................... 12

C. Long-Term Follow-up Schedule for Hypertrophic Cardiomyopathy ................................................... 13
V. NON-COMPACTION CARDIOMYOPATHY ................................................................................................ 14

A. Initial Evaluation for Patient with Non-Compaction Cardiomyopathy ............................................... 14
B. Long-Term Medical Management for Non-Compaction Cardiomyopathy ......................................... 14

C. Long-Term Follow-up Schedule for Non-Compaction Cardiomyopathy ............................................ 14
VI. CONGENITAL HEART DISEASE WITH HEART FAILURE ............................................................................ 15
A. Initial Evaluation for Patient with Congenital Heart Disease with Heart Failure ............................... 15

B. Management and Long-Term Follow-up for Congenital Heart Disease with Heart Failure ............... 15
VII. ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ............................................................ 16

A. Initial Evaluation for Patient with Arrhythmogenic Right Ventricular Cardiomyopathy .................... 16
B. Long-Term and Medical Management for Arrhythmogenic Right Ventricular Cardiomyopathy ....... 16
VIII. CHEMOTHERAPY INDUCED CARDIOMYOPATHY ................................................................................. 17

A. Initial Evaluation for Patient with Chemotherapy Induced Cardiomyopathy .................................... 17
B. Long-Term Medical Management for Chemotherapy-Induced Cardiomyopathy .............................. 17